Literature DB >> 21294415

Determination of cytotoxic compounds of Thai traditional medicine called Benjakul using HPLC.

Arunporn Itharat1, Intouch Sakpakdeejaroen.   

Abstract

Benjakul is a Thai traditional medicine preparation, used for balanced health. From selective interviews of folk doctors in southern Thailand, it was used as the adaptogen drug for cancer patients. In our previous study, the ethanolic extract of Benjakul preparation exhibited high cytotoxic activity against lung cancer cell lines (COR-L23). Piperine has been identified as the main compound in the extract. In addition, plumbagin was found as the most cytotoxic compound. In this study, a reversed-phase high performance liquid chromatography (HPLC) method for quality control such as chemical fingerprint, quantification and stability of the ethanolic extract of Benjakul preparation was developed. The reversed-phase HPLC was performed with a gradient mobile phase composed of water and acetronitrile, and peaks were detected at 256 nm. Based on validation results, this analytical method is precise, accurate and stable for quantitative determination of piperine and plumbagin which are cytotoxic compounds isolated from the ethanolic extract of Benjakul preparation. This method could be suitable for analysis of Benjakul extract.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21294415

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Clinical Efficacy and Safety of Benjakul Remedy Extract for Treating Primary Osteoarthritis of Knee Compared with Diclofenac: Double Blind, Randomized Controlled Trial.

Authors:  Patamaporn Rachawat; Piya Pinsornsak; Puritat Kanokkangsadal; Arunporn Itharat
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-12       Impact factor: 2.629

2.  Development and optimization of Benjakul microemulsion formulations for enhancing topical anti-inflammatory effect and delivery.

Authors:  Pranporn Kuropakornpong; Arunporn Itharat; Buncha Ooraikul; Raimar Loebenberg; Neal M Davies
Journal:  Res Pharm Sci       Date:  2022-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.